Finance Watch: Venture Capital On Track For Another Record Year

Venture capital investment in biopharmaceutical companies during the second quarter brought another set of staggering numbers, with 257 firms raising $8.9bn – the second highest quarterly dollar total going back to 2006, according to data from Pitchbook and the National Venture Capital Association’s Venture Monitor report released on 14 July.

Q2 was second only to the first quarter of 2021, when $11.4bn was invested in 339 biopharma ventures (revised from a previous sum of $10.5bn). (Also see "Finance Watch: Biotech Venture Capital Had Its Biggest Quarter Ever" - Scrip, 28 April, 2021.) This year is well on its way to beating the record set in 2020 when 1,043 companies raised $27.2bn (revised from $27.4bn). (Also see "Finance Watch: Biopharma VC Deals Hit New Record Of $27.4bn In 2020" - Scrip, 18 January, 2021